EVALUATION OF HOSPITAL MORBITY AND NEOPLASM MORTALITY: 2015 – 2019
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Revista Ciência Plural |
Texto Completo: | https://periodicos.ufrn.br/rcp/article/view/25195 |
Resumo: | Introduction: Currently, one of the biggest public health problems is chronic non-communicable diseases, which have generated a high number of premature deaths. Objective: To analyze hospital morbidity and mortality in the population aged between 10 and 59 years in Brazil, in the period from 2015 to 2019. Methodology: This is a quantitative, observational study, whose research method is characterized by an ecological epidemiological study of time series in a historical series of the last five years (2015-2019) available in mid-April 2021, and extracted from the national public domain base of the Ministry of Health entitled DATASUS - SUS Informatics Department. Results: It was observed that the distribution of the mortality rate due to neoplasia, per 100,000 inhabitants due to CID-BR-10 in a population aged between 10 and 59 years, was due to malignant neoplasm of the breast, as the second leading cause of deaths due to neoplasia in the five-year period, followed by malignant neoplasm of the trachea, bronchi and lungs, malignant neoplasm of the colon, rectum and anus, malignant neoplasm of the stomach and malignant neoplasm of the meninges, brain and other parts of the central nervous system. Regarding the hospital morbidity rate from the most prevalent causes, it is observed that the uterus leiomyoma has the highest average in the period observed (39,454), median of 38.88 and standard deviation of 2.03, followed by other in situ neoplasms and benign neoplasms and neoplasms of uncertain or unknown behavior with a mean of 31,724, a median of 30.88 and a standard deviation of 0.66. Conclusions: The analysis of health indicators for neoplasms shows the growing trend in the five years of hospital morbidity and mortality. So that they stand out that they are the target of more research and attention. |
id |
UFRN-4_62cf9c17931589858c4b78a5351eb2e4 |
---|---|
oai_identifier_str |
oai:periodicos.ufrn.br:article/25195 |
network_acronym_str |
UFRN-4 |
network_name_str |
Revista Ciência Plural |
repository_id_str |
|
spelling |
EVALUATION OF HOSPITAL MORBITY AND NEOPLASM MORTALITY: 2015 – 2019EVALUACIÓN DE MORBIDAD HOSPITALARIA Y MORTALIDAD POR NEOPLASMA: 2015-2019AVALIAÇÃO DA MORBIDADE HOSPITALAR E MORTALIDADE POR NEOPLASIA: 2015 - 2019Introduction: Currently, one of the biggest public health problems is chronic non-communicable diseases, which have generated a high number of premature deaths. Objective: To analyze hospital morbidity and mortality in the population aged between 10 and 59 years in Brazil, in the period from 2015 to 2019. Methodology: This is a quantitative, observational study, whose research method is characterized by an ecological epidemiological study of time series in a historical series of the last five years (2015-2019) available in mid-April 2021, and extracted from the national public domain base of the Ministry of Health entitled DATASUS - SUS Informatics Department. Results: It was observed that the distribution of the mortality rate due to neoplasia, per 100,000 inhabitants due to CID-BR-10 in a population aged between 10 and 59 years, was due to malignant neoplasm of the breast, as the second leading cause of deaths due to neoplasia in the five-year period, followed by malignant neoplasm of the trachea, bronchi and lungs, malignant neoplasm of the colon, rectum and anus, malignant neoplasm of the stomach and malignant neoplasm of the meninges, brain and other parts of the central nervous system. Regarding the hospital morbidity rate from the most prevalent causes, it is observed that the uterus leiomyoma has the highest average in the period observed (39,454), median of 38.88 and standard deviation of 2.03, followed by other in situ neoplasms and benign neoplasms and neoplasms of uncertain or unknown behavior with a mean of 31,724, a median of 30.88 and a standard deviation of 0.66. Conclusions: The analysis of health indicators for neoplasms shows the growing trend in the five years of hospital morbidity and mortality. So that they stand out that they are the target of more research and attention.Introducción: Actualmente, uno de los mayores problemas de salud pública son las enfermedades crónicas no transmisibles, las cuales han generado un elevado número de muertes prematuras. Objetivo: Analizar la morbilidad y mortalidad hospitalaria en la población de 10 a 59 años en Brasil, en el período de 2015 a 2019. Metodología: Se trata de un estudio observacional cuantitativo, cuyo método de investigación se caracteriza por un estudio epidemiológico ecológico de series de tiempo en una serie histórica de los últimos cinco años (2015-2019) disponible a mediados de abril de 2021, y extraída de la base de dominio público nacional. del Ministerio de Salud titulado DATASUS - Departamento de Informática del SUS. Resultados: Se observó que la distribución de la tasa de mortalidad por neoplasia, por 100.000 habitantes por CID-BR-10 en una población de entre 10 y 59 años, se debió a neoplasia maligna de mama, como segunda causa de muerte. debido a neoplasia en el período de cinco años, seguida de neoplasia maligna de la tráquea, bronquios y pulmones, neoplasia maligna del colon, recto y ano, neoplasia maligna del estómago y neoplasia maligna de las meninges, cerebro y otras partes del sistema nervioso central. En cuanto a la tasa de morbilidad hospitalaria por las causas más prevalentes, se observa que el leiomioma de útero tiene el promedio más alto en el período observado (39.454), mediana de 38,88 y desviación estándar de 2,03, seguido de otras neoplasias in situ y neoplasias y neoplasias benignas de comportamiento incierto o desconocido con una media de 31.724, una mediana de 30,88 y una desviación estándar de 0,66. Conclusiones: El análisis de los indicadores de salud por neoplasias muestra la tendencia creciente en los cinco años de morbilidad y mortalidad hospitalaria. Para que destaquen que son objeto de más investigación y atención.Introdução: Atualmente, um dos maiores problemas de saúde pública trata-se das doenças crônicas não transmissíveis, que têm gerado elevado número de mortes prematuras. Objetivo: Analisar a morbidade hospitalar e mortalidade na população com faixa-etária entre 10 e 59 anos no Brasil, no período de 2015 a 2019. Metodologia: Trata-se de um estudo quantitativo, do tipo observacional, cujo método de investigação caracteriza-se por um estudo epidemiológico ecológico de série temporal em uma série histórica dos últimos cinco anos (2015-2019) disponíveis em meados de Abril de 2021, e extraídos da base nacional de domínio público do Ministério da Saúde intitulada DATASUS - Departamento de Informática do SUS. Resultados: Observou-se que a distribuição da taxa de mortalidade por neoplasia, por 100.000 habitantes por Causa CID-BR-10 em população com faixa etária entre 10 e 59 anos, se deu por Neoplasia maligna da mama, como segunda causa de mortes por Neoplasia no quinquênio, seguido por Neoplasia maligna da traquéia, dos brônquios e dos pulmões, Neoplasia maligna do cólon, do reto e do ânus, Neoplasia maligna do estômago e Neoplasia maligna das meninges, do encéfalo e de outras partes do sistema nervoso central. Quanto a taxa de morbidade hospitalar a partir das causas de maior prevalência observa-se que o Leiomioma do útero apresenta maior média no período observado (39.454), mediana de 38.88 e desvio padrão de 2.03, seguido por outras neoplasias in situ e neoplasias benignas e neoplasias de comportamento incerto ou desconhecido com média em 31.724, mediana 30.88 e desvio padrão 0.66. Conclusões: A análise de indicadores da saúde por neoplasias demonstra a tendencia crescente no quinquênio da morbidade hospitalar e mortalidade. De modo que se destacam que sejam alvo de maiores pesquisas e atenções.Portal de Periódicos Eletrônicos da UFRN2021-08-27info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigo avaliado pelos Paresapplication/pdfhttps://periodicos.ufrn.br/rcp/article/view/2519510.21680/2446-7286.2021v7n3ID25195Revista Ciência Plural; v. 7 n. 3 (2021): Revista Ciência Plural; 235-2502446-728610.21680/2446-7286.2021v7n3reponame:Revista Ciência Pluralinstname:Universidade Federal do Rio Grande do Norte (UFRN)instacron:UFRNporhttps://periodicos.ufrn.br/rcp/article/view/25195/14664Copyright (c) 2021 Revista Ciência Pluralinfo:eu-repo/semantics/openAccessSantos Ferreira, Tainara Lorena dosBarbosa Neta Silva, Rita XavierMorais, Thiffany Nayara Bento deAndrade, Fábia Barbosa de 2021-09-14T01:19:43Zoai:periodicos.ufrn.br:article/25195Revistahttps://periodicos.ufrn.br/rcpPUBhttps://periodicos.ufrn.br/rcp/oai||irisdoceu.ufrn@gmail.com2446-72862446-7286opendoar:2021-09-14T01:19:43Revista Ciência Plural - Universidade Federal do Rio Grande do Norte (UFRN)false |
dc.title.none.fl_str_mv |
EVALUATION OF HOSPITAL MORBITY AND NEOPLASM MORTALITY: 2015 – 2019 EVALUACIÓN DE MORBIDAD HOSPITALARIA Y MORTALIDAD POR NEOPLASMA: 2015-2019 AVALIAÇÃO DA MORBIDADE HOSPITALAR E MORTALIDADE POR NEOPLASIA: 2015 - 2019 |
title |
EVALUATION OF HOSPITAL MORBITY AND NEOPLASM MORTALITY: 2015 – 2019 |
spellingShingle |
EVALUATION OF HOSPITAL MORBITY AND NEOPLASM MORTALITY: 2015 – 2019 Santos Ferreira, Tainara Lorena dos |
title_short |
EVALUATION OF HOSPITAL MORBITY AND NEOPLASM MORTALITY: 2015 – 2019 |
title_full |
EVALUATION OF HOSPITAL MORBITY AND NEOPLASM MORTALITY: 2015 – 2019 |
title_fullStr |
EVALUATION OF HOSPITAL MORBITY AND NEOPLASM MORTALITY: 2015 – 2019 |
title_full_unstemmed |
EVALUATION OF HOSPITAL MORBITY AND NEOPLASM MORTALITY: 2015 – 2019 |
title_sort |
EVALUATION OF HOSPITAL MORBITY AND NEOPLASM MORTALITY: 2015 – 2019 |
author |
Santos Ferreira, Tainara Lorena dos |
author_facet |
Santos Ferreira, Tainara Lorena dos Barbosa Neta Silva, Rita Xavier Morais, Thiffany Nayara Bento de Andrade, Fábia Barbosa de |
author_role |
author |
author2 |
Barbosa Neta Silva, Rita Xavier Morais, Thiffany Nayara Bento de Andrade, Fábia Barbosa de |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Santos Ferreira, Tainara Lorena dos Barbosa Neta Silva, Rita Xavier Morais, Thiffany Nayara Bento de Andrade, Fábia Barbosa de |
description |
Introduction: Currently, one of the biggest public health problems is chronic non-communicable diseases, which have generated a high number of premature deaths. Objective: To analyze hospital morbidity and mortality in the population aged between 10 and 59 years in Brazil, in the period from 2015 to 2019. Methodology: This is a quantitative, observational study, whose research method is characterized by an ecological epidemiological study of time series in a historical series of the last five years (2015-2019) available in mid-April 2021, and extracted from the national public domain base of the Ministry of Health entitled DATASUS - SUS Informatics Department. Results: It was observed that the distribution of the mortality rate due to neoplasia, per 100,000 inhabitants due to CID-BR-10 in a population aged between 10 and 59 years, was due to malignant neoplasm of the breast, as the second leading cause of deaths due to neoplasia in the five-year period, followed by malignant neoplasm of the trachea, bronchi and lungs, malignant neoplasm of the colon, rectum and anus, malignant neoplasm of the stomach and malignant neoplasm of the meninges, brain and other parts of the central nervous system. Regarding the hospital morbidity rate from the most prevalent causes, it is observed that the uterus leiomyoma has the highest average in the period observed (39,454), median of 38.88 and standard deviation of 2.03, followed by other in situ neoplasms and benign neoplasms and neoplasms of uncertain or unknown behavior with a mean of 31,724, a median of 30.88 and a standard deviation of 0.66. Conclusions: The analysis of health indicators for neoplasms shows the growing trend in the five years of hospital morbidity and mortality. So that they stand out that they are the target of more research and attention. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-08-27 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Artigo avaliado pelos Pares |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://periodicos.ufrn.br/rcp/article/view/25195 10.21680/2446-7286.2021v7n3ID25195 |
url |
https://periodicos.ufrn.br/rcp/article/view/25195 |
identifier_str_mv |
10.21680/2446-7286.2021v7n3ID25195 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://periodicos.ufrn.br/rcp/article/view/25195/14664 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2021 Revista Ciência Plural info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2021 Revista Ciência Plural |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Portal de Periódicos Eletrônicos da UFRN |
publisher.none.fl_str_mv |
Portal de Periódicos Eletrônicos da UFRN |
dc.source.none.fl_str_mv |
Revista Ciência Plural; v. 7 n. 3 (2021): Revista Ciência Plural; 235-250 2446-7286 10.21680/2446-7286.2021v7n3 reponame:Revista Ciência Plural instname:Universidade Federal do Rio Grande do Norte (UFRN) instacron:UFRN |
instname_str |
Universidade Federal do Rio Grande do Norte (UFRN) |
instacron_str |
UFRN |
institution |
UFRN |
reponame_str |
Revista Ciência Plural |
collection |
Revista Ciência Plural |
repository.name.fl_str_mv |
Revista Ciência Plural - Universidade Federal do Rio Grande do Norte (UFRN) |
repository.mail.fl_str_mv |
||irisdoceu.ufrn@gmail.com |
_version_ |
1799770062736850944 |